Connection

RITSUKO KOMAKI to Mutagenicity Tests

This is a "connection" page, showing publications RITSUKO KOMAKI has written about Mutagenicity Tests.
Connection Strength

0.249
  1. Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. Semin Oncol. 2005 Apr; 32(2 Suppl 3):S92-8.
    View in: PubMed
    Score: 0.249
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.